Bioretec has a total of 108 patents globally, out of which 57 have been granted. Of these 108 patents, more than 32% patents are active. United States of America is where Bioretec has filed the maximum number of patents, followed by Europe and Finland. Parallelly, Finland seems to be the main focused R&D centre and also is the origin country of Bioretec.
Bioretec was founded in the year 2003. The Company is a Finnish material technology company focused on the development, manufacturing and marketing of bioabsorbable, bioactive and drug-releasing surgical implants for orthopedic, trauma and sport medicine surgeries.
Do read about some of the most popular patents of Bioretec which have been covered by us in this article and also you can find Bioretec patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Bioretec patent portfolio.
How many patents does the CEO of Bioretec have?
The CEO Timo Lehtonen has 4 patents.
How many patents does Bioretec have?
Bioretec has a total of 108 patents globally. These patents belong to 35 unique patent families. Out of 108 patents, 35 patents are active.
How Many Patents did Bioretec File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
|Year of Patents Filing or Grant||Bioretec Applications Filed||Bioretec Patents Granted|
How many Bioretec patents are Alive/Dead?
How Many Patents did Bioretec File in Different Countries?
Countries in which Bioretec Filed Patents
|United States Of America||22|
|Hong Kong (S.A.R.)||1|
Where are Research Centres of Bioretec Patents Located?
10 Best Bioretec Patents
US7964206B2 is the most popular patent in the Bioretec portfolio. It has received 862 citations so far from companies like Prosidian, Cibor and Vertera.
Below is the list of 10 most cited patents of Bioretec:
|Publication Number||Citation Count|
How many inventions of other companies were rejected due to Bioretec patents?
The statistics below share strategic R&D insights. It tells the companies that were trying to protect inventions similar to Bioretec invention. They couldn’t because Bioretec had protected those before them.
Examiners at the USPTO referred 14 Bioretec patents in 76 rejections (35 USC § 102 or 35 USC § 103 types).
The top citing companies in the Bioretec patent portfolio are Cormatrix Cardiovascular, Cook Medical Technologies and Warsaw Orthopedic.
List of the Companies whose Patents were rejected citing Bioretec –
|Company||Number of Patent Applications that faced Rejection Citing Bioretec Patents||Number of Rejections (102 & 103)|
|Cook Medical Technologies||2||3|
|Smith & Nephew||1||5|
|National Cerebral And Cardiovascular Center||1||4|
|Abbott Cardiovascular Systems||1||1|
Count of 102 and 103 Type Rejections based on Bioretec Patents
Top Bioretec Patents used in Rejecting Most Patent Applications
|Patent Number||Count of Rejected Applications|
What Percentage of Bioretec US Patent Applications were Granted?
Bioretec (Excluding its subsidiaries) has filed 22 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 11 have been granted leading to a grant rate of 52.38%.
Below are the key stats of Bioretec patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Bioretec?
|Law Firm||Total Applications||Success Rate|
|Hunton Andrews Kurth||4||50.00%|
|Meunier Carlin & Curfman||4||100.00%|
|John R Hutchins||1||100.00%|
What are Bioretec key innovation segments?
What Technologies are Covered by Bioretec?
The chart below distributes patents filed by Bioretec